Search research articles
Contact Us
Filters
Showing results (381-390 of 424) with videos related to
Page
of 43
Sort By:
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial
Michael J Corley, Maya Watanabe, Alina P S Pang, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Contemporary Clinical Trials
|
December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial
Evelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
The Journal of Infectious Diseases
|
October 17, 2020
Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 424) with videos related to
Sort By:
Page
of 43
JAMA Cardiology
|
December 11, 2024
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial
Márton Kolossváry, Samuel R Schnittman, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV
Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum, et al.
AIDS (London, England)
|
June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV
Kristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV
|
April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial
Marissa R Diggs, Triin Umbleja, Sara McCallum, et al.
JACC. Advances
|
August 21, 2025
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
Kristine M Erlandson, Ariela R Orkaby, Triin Umbleja, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial
Michael J Corley, Maya Watanabe, Alina P S Pang, et al.
AIDS (London, England)
|
July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIV
Kristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Contemporary Clinical Trials
|
December 3, 2022
The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial
Evelynne S Fulda, Carl J Fichtenbaum, Emma M Kileel, et al.
The Journal of Infectious Diseases
|
October 17, 2020
Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
Carl J Fichtenbaum, Heather J Ribaudo, Jorge Leon-Cruz, et al.
Page
of 43